title: [Prostatectomy, brachytherapy, percutaneous irradiation. Which method helps your patients the most?].
abstract: For the treatment of cancer of the prostate that has not yet metastasized, several therapeutic options that promise lasting local tumour control are now available: Among the surgical options, radical retropubic prostatectomy is most commonly employed. The basic radiotherapeutic options are interstitial and external beam irradiation, or a combination of the two. The choice of the most suitable therapeutic approach is determined by the extent of the tumor, and the side effects that are acceptable to the patient.
authors.affiliation: Abteilung für Strahlentherapie, Universität Ulm.
authors.forename: P M
authors.initials: PM
authors.lastname: Messer
authors.forename: H W
authors.initials: HW
authors.lastname: Gottfried
authors.forename: R
authors.initials: R
authors.lastname: Hautmann
authors.forename: E M
authors.initials: EM
authors.lastname: Röttinger
mesh_terms: D001918:Brachytherapy; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D011880:Radiotherapy Planning, Computer-Assisted
chemical_list: D017430:Prostate-Specific Antigen